Over the past ten years, Janssen has advanced ten new oncology drugs through regulatory approval, including several first-in-class medicines (Fig. 1). Among these are the first fully human bispecific antibody for lung cancer, the first Bruton’s tyrosine kinase (BTK) inhibitor for B cell malig...
Our research pipeline is rich with transformational science reflecting our unique approach to innovation. See More > R&D Data Science Using data science and digital health to reimagine the discovery and development of medicines to advance our mission of bringing transformative therapies to patients...
In this role, Joaquin was responsible for the generation of actionable customer analytics and insights to help the Neurodegeneration team identify ways to build and maximize the value of its global pipeline assets. He was the market research lead on a wide range of programs related to the future...
M.D., Ph.D., Executive Vice President, Chief External Innovation and Medical Officer and Interim Head, Janssen R&D. “We remain focused on advancing our differentiated pipeline, improving the lives of millions of patients and developing new modalities in areas with the greatest unmet medical need...
“The collaboration strengthens our financial and operating position through a focused effort of developing cell-based cancer immunotherapies utilizing Janssen’s proprietary antigen binding domains, while enabling us to continue to exploit our deep pipeline of wholly-owned product candidates...
‘pipeline in a pathway,’” said Mathai Mammen, M.D., Ph.D., Global Head of Janssen Research & Development,Johnson & Johnson. “We are excited about the significant potential to expand on Momenta’s excellent progress in rare diseases,...
How are Janssen’s current product pipeline and other innovations poised to further help people living with PAH? We are advancing more than 21 active projects across the R&D pipeline for new disease-modifying treatments and novel therapeutic devices related to PH. We’ve been working on...
Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. "We're excited by the opportunity to further advance patient care by combining Johnson & Johnson's world-class R&D, commercial and supply chain capabilities with Momenta's talente...
The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has...
“We remain focused on advancing our differentiated pipeline, improving the lives of millions of patients and developing new modalities in areas with the greatest unmet medical need.” About the Janssen Pharmaceutical Companies of Johnson & JohnsonAt Janssen, we’re creating a future where disease ...